Adult acne patients who can get pregnant must pass two negative pregnancy tests in a medical setting before starting isotretinoin under iPLEDGE in 2026. iPLEDGE is the FDA-required safety program that links testing, contraception, prescriber enrollment, and pharmacy authorization for isotretinoin. Isotretinoin is for severe recalcitrant nodular acne unresponsive to conventional therapy including systemic antibiotics in nonpregnant patients 12 and older.
Drugs.com reporting on the FDA announcement says the agency approved iPLEDGE changes on Feb. 9, 2026, effective Aug. 9, 2026 the FDA approval notice.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who needs testing before isotretinoin?
- Where and when do the two pretreatment tests happen?
- How do contraception and the pickup deadline fit?
- What should you verify before your first prescription?
Who needs testing before isotretinoin?
The FDA drug label gives isotretinoin a boxed warning for embryo-fetal toxicity and contraindicates it in pregnancy. Testing applies to patients who can get pregnant, not to every adult acne patient the same way.
All patients must enroll in iPLEDGE, including adults treating acne. Only enrolled and activated prescribers may prescribe, and only enrolled and activated pharmacies may dispense. Pregnancy results, contraception, and counseling must be entered for authorization.
Where and when do the two pretreatment tests happen?
The FDA iPLEDGE REMS Medical Organizations Letter states that patients who can get pregnant need two negative tests in a medical setting before treatment the FDA medical organizations letter. Acceptable settings include prescriber office, clinic, or laboratory.
The first test is a screening test when the decision to prescribe is made. The second test confirms the result after the waiting period. Pretreatment tests cannot be done at home.
How do contraception and the pickup deadline fit?
Patients who can become pregnant must use two effective contraception forms at the same time, continuously for one month before, during, and for one month after isotretinoin. The exception is a commitment to continuous abstinence from penis-vaginal sexual contact.
The American Academy of Dermatology Association states that the first prescription must be picked up within a 7-day window after test confirmation the Academy update. If that window is missed, get a repeat confirmatory pregnancy test in a medical setting immediately. No new waiting period applies because the prior 19-day lockout was removed.
What should you verify before your first prescription?
Monthly pregnancy testing is still required before each prescription for patients who can get pregnant. During and after treatment, prescribers may allow home tests, and CLIA-certified laboratory testing is no longer mandatory.
Use this checklist at the prescribing visit: Prescribers who allow home tests later must have procedures to reduce misinterpretation and falsification. Ask how to report the result, what proof the office needs, and what happens if a test is missed or unclear.
- Confirm both pretreatment tests will occur in a medical setting.
- Confirm screening date, confirmatory date, and 7-day pickup deadline.
- Confirm your two contraception methods or abstinence plan cover the full before, during, and after periods.
- Confirm prescriber and pharmacy enrollment, plus monthly follow-up testing.
You Might Also Like
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Which Rules Apply Now for Adult Acne Patients
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: A Verification Checklist for Adult Acne Patients
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Which Rules Apply Now for Adult Acne Patients